Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026)
Sarepta Therapeutics' quarterly Prepaid Assets came in at $2.2 million in Q1 2026, down 97.9% year-on-year from $105.5 million in Q1 2025, and down 44.63% quarter-over-quarter from $4.0 million in Q4 2025.
Sarepta Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 97.9% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 97.9% YoY), and the FY2025 full-year result was $4.0 million, down 95.57% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.2 million, down from $4.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $179.8 million in Q1 2023, with the low at $1.2 million in Q3 2022.
- Average Prepaid Assets over 5 years is $41.1 million, with a median of $3.4 million recorded in 2023.
- Year-over-year, Prepaid Assets sank 99.17% in 2022 and soared 5303.59% in 2025.
- Tracing SRPT's Prepaid Assets over 5 years: stood at $149.9 million in 2022, then plunged by 97.76% to $3.4 million in 2023, then jumped by 2598.72% to $90.5 million in 2024, then sank by 95.57% to $4.0 million in 2025, then tumbled by 44.63% to $2.2 million in 2026.
- The last three Prepaid Assets figures came in at $2.2 million (Q1 2026), $4.0 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 4.11 Mn |
| Mar 31, 2025 | 105.48 Mn |
| Dec 31, 2024 | 90.46 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.93 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 179.77 Mn |
| Dec 31, 2022 | 149.89 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 140.33 Mn |
| Dec 31, 2021 | 149.03 Mn |
| Sep 30, 2021 | 147.94 Mn |
| Jun 30, 2021 | 141.67 Mn |
| Mar 31, 2021 | 174.98 Mn |
| Dec 31, 2020 | 4.16 Mn |
| Sep 30, 2020 | 5.53 Mn |
| Jun 30, 2020 | 1.37 Mn |
| Mar 31, 2020 | 1.42 Mn |
| Dec 31, 2019 | 81.91 Mn |
| Sep 30, 2019 | 2.13 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Mar 31, 2019 | 2.13 Mn |
| Dec 31, 2018 | 2.13 Mn |
| Sep 30, 2018 | 54.80 Mn |
| Jun 30, 2018 | 2.50 Mn |
| Mar 31, 2018 | 2.19 Mn |
| Dec 31, 2017 | 2.73 Mn |
| Sep 30, 2017 | 4.00 Mn |
| Jun 30, 2017 | 28.57 Mn |
| Mar 31, 2017 | 1.51 Mn |
| Dec 31, 2016 | 989,000.00 |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | 2.73 Mn |
| Mar 31, 2016 | 16.89 Mn |
| Dec 31, 2015 | 17.38 Mn |
| Sep 30, 2015 | 4.38 Mn |
| Jun 30, 2015 | 23.09 Mn |
| Mar 31, 2015 | 3.31 Mn |
| Dec 31, 2014 | 2.80 Mn |
| Sep 30, 2014 | 26.44 Mn |
| Jun 30, 2014 | 15.91 Mn |
| Mar 31, 2014 | 9.08 Mn |
| Dec 31, 2013 | 3.06 Mn |
| Sep 30, 2013 | 2.81 Mn |
| Jun 30, 2013 | 5.68 Mn |
| Mar 31, 2013 | 3.02 Mn |
| Dec 31, 2012 | 1.53 Mn |
| Mar 31, 2012 | 1.92 Mn |
| Dec 31, 2011 | 1.65 Mn |
| Sep 30, 2011 | 1.32 Mn |
| Jun 30, 2011 | 943,000.00 |
| Dec 31, 2010 | 1.03 Mn |